Endpoints for homocysteine-lowering trials

Lancet. 2000 Feb 12;355(9203):511-2. doi: 10.1016/S0140-6736(99)00437-7.
No abstract available

Publication types

  • Comment

MeSH terms

  • Adult
  • Aged
  • Child
  • Coronary Artery Disease / etiology*
  • Coronary Artery Disease / prevention & control
  • Folic Acid / therapeutic use
  • Hematinics / therapeutic use
  • Humans
  • Hyperhomocysteinemia / complications*
  • Hyperhomocysteinemia / drug therapy*
  • Pyridoxine / therapeutic use

Substances

  • Hematinics
  • Folic Acid
  • Pyridoxine